For its first fiscal quarter (ending March 31), Johnson & Johnson (NYSE: JNJ) has reported E.P.S. of $2.20 compared to $-0.03 a year ago. For the latest four quarters through March 31, E.P.S. were $7.53 versus $4.25 for the same period a year ago.
Recent Price Action
Johnson & Johnson (NYSE: JNJ) stock declined by -2.1% on 4/16/24. The shares closed at $144.45. Moreover, this decline was accompanied by unusually high trading volume at 174% of normal. The stock has been weak relative to the market over the last nine months and has declined -4.7% during the last week.
Current PriceTarget Research Rating
JNJ’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
Johnson & Johnson has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Johnson & Johnson has a slightly negative Power Rating of 37 and a poor Appreciation Score of 25, producing the Lowest Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment